Literature DB >> 11915975

Development and maintenance of a community-based hepatitis C registry.

Barbara P Yawn1, Lilliana Gazzuola, Peter C Wollan, W Ray Kim.   

Abstract

OBJECTIVE: To develop a model for community-population- or health system-based registries of all patients with diagnosed hepatitis C, to facilitate clinical care and epidemiologic studies. STUDY
DESIGN: Geographically defined, population-based cohort study.
METHODS: Registry subjects were identified using January 1, 1990, to December 31, 1999, data from the Rochester Epidemiology Project (REP), which lists all diagnoses for Olmsted County residents recorded by clinicians during visits to Olmsted County medical providers. We supplemented diagnostic data with information from laboratory databases that record all hepatitis C testing in Olmsted County. All diagnoses based on the REP and laboratory databases were confirmed by medical record review. Proposed data elements to be included in a hepatitis C registry were identified and defined, and data collection methodology was tested.
RESULTS: A total of 355 subjects (62% male) were identified in the total community population of 130,000. Both the diagnostic summary database (n = 309, 87%) and the laboratory database (n = 46, 133%) were important in the identification of subjects for the registry. Nine additional subjects with diagnostic or laboratory evidence of hepatitis C refused the legislatively mandated (Minnesota statute) medical records research authorization and could not be included in the registry. Most desired data elements were available in the medical records.
CONCLUSIONS: Both medical visit diagnostic summaries (administrative or billing data) and laboratory databases are required to identify subjects with physician-based diagnoses of hepatitis C. Few patients refused the authorization required for inclusion in a research registry.

Entities:  

Mesh:

Year:  2002        PMID: 11915975

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  4 in total

Review 1.  Global registries for measuring pharmacoeconomic and quality-of-life outcomes: focus on design and data collection, analysis and interpretation.

Authors:  Lisa Kennedy; Ann-Marie Craig
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

2.  Management of patients with hepatitis C in a community population: diagnosis, discussions, and decisions to treat.

Authors:  Liliana Gazzuola Rocca; Barbara P Yawn; Peter Wollan; W Ray Kim
Journal:  Ann Fam Med       Date:  2004 Mar-Apr       Impact factor: 5.166

3.  10-year trends in the diagnosis and treatment of hepatitis C and concomitant mental health disorders: 1995 to 2005.

Authors:  Barbara P Yawn; Liliana Gazzuola Rocca; Peter C Wollan
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

4.  Population-based surveillance for hepatitis C virus, United States, 2006-2007.

Authors:  R Monina Klevens; Jeremy Miller; Candace Vonderwahl; Suzanne Speers; Karen Alelis; Kristin Sweet; Elena Rocchio; Tasha Poissant; Tara M Vogt; Kathleen Gallagher
Journal:  Emerg Infect Dis       Date:  2009-09       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.